|
|
Volumn 21, Issue 3, 2012, Pages
|
|
SnapShot: Non-Small Cell Lung Cancer
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
4 DIALLYLAMINOMETHYLENE 1,3,4,7,10,11,12,13,14,15,16,17 DODECAHYDRO 6 HYDROXY 1 METHOXYMETHYL 10,13 DIMETHYL 3,7,17 TRIOXO 2 OXACYCLOPENTA[A]PHENANTHREN 11 YL ACETATE;
8 [4 (1 AMINOCYCLOBUTYL)PHENYL] 9 PHENYL 1,2,4 TRIAZOLO[3,4 F][1,6]NAPHTHYRIDIN 3(2H) ONE;
AF 802;
AFATINIB;
ANTINEOPLASTIC AGENT;
AP 26113;
ARRY 438162;
BGJ 398;
BRIVANIB;
BRIVANIB ALANINATE;
BUPARLISIB;
CRIZOTINIB;
DACOMITINIB;
DOVITINIB;
ERLOTINIB;
FP 1039;
GDC 0973;
GEFITINIB;
IMC 3 G 3;
LDK 378;
LENVATINIB;
MEDI 575;
MKK 2206;
MSC 1936369 B;
MSC 1936369B;
NINTEDANIB;
OPB 51602;
PAZOPANIB;
PICTILISIB;
PONATINIB;
TRAMETINIB;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
XL 147;
CANCER CHEMOTHERAPY;
CANCER RADIOTHERAPY;
CANCER STAGING;
CANCER SURGERY;
CANCER SURVIVAL;
CANCER THERAPY;
DRUG TARGETING;
GENE MUTATION;
LUNG ADENOCARCINOMA;
LUNG NON SMALL CELL CANCER;
LUNG SQUAMOUS CELL CARCINOMA;
MULTIMODALITY CANCER THERAPY;
OVERALL SURVIVAL;
PRIORITY JOURNAL;
SHORT SURVEY;
|
|
EID: 84858590519
PISSN: 15356108
EISSN: 18783686
Source Type: Journal
DOI: 10.1016/j.ccr.2012.03.007 Document Type: Short Survey |
|
Times cited : (172)
|
|
References (0)
|
